MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2024 International Congress

    Critically Evaluating Best Practice Guidelines for Cognitive Impairment in Parkinson’s Disease: A Systematic Review (PDCogniCare)

    D. Pourzinal, D. Bailey, J. Yang, L. Mitchell, N. Pachana, D. Brooks, SA. Keramat, K. Shrubsole, J. Liddle, H. Tinson, S. Naismith, A. Lehn, R. Marsh, N. Dissanayaka (HERSTON, Australia)

    Objective: This systematic review aimed to critically evaluate current recommendations for evaluation, diagnosis and post-diagnostic care of cognitive impairment in Parkinson's disease (PD). Background: Methods…
  • 2024 International Congress

    Exploring the Influence of Gastrointestinal Symptoms on Non-Motor Fluctuations in Parkinson’s Disease: Insights from the ReMePark-2, a Mexican Cohort

    A. Cervantes-Arriaga, AJ. Hernández Medrano, AL. Guerra-Anzaldo, A. Domínguez-García, DP. Romero-Terán, G. Rivera-Monroy, KI. Sánchez-Ramírez, MF. Medina-Pérez, M. Rodríguez-Violante, R. Baños-Betancourt, A. Abundes-Corona, SF. Arechavala Lopez, WF. Moguel-Cardín ()

    Objective: To determine the impact of gastrointestinal symptoms on NMF in PD among Mexican individuals living with PD (PwP). Background: The growing interest in the…
  • 2024 International Congress

    Autonomic Dysfunction in Parkinson’s Disease Link with disease severity and other non-motor signs

    A. Mousli, R. Zouari, A. Rachdi, F. Nabli, D. Ben Mohamed, Z. Saeid, S. Ben Sassi (Ariana, Tunisia)

    Objective: Clarify the relationship between autonomic dysfunction, disease severity and NMS in PD patients. Background: Parkinson’s disease (PD) is characterized by a combination of motor…
  • 2024 International Congress

    The Association between Non-Motor Symptom Burden and Quality of Life in the Nigeria Parkinson Disease Research Network Registry

    O. Odeniyi, O. Ojo, O. Agabi, N. Okubadejo, NPD. Research Network (Lagos, Nigeria)

    Objective: To determine the relationship between non-motor symptom (NMS) burden and quality of life in persons living with Parkinson’s disease (PD) recruited into the registry.…
  • 2024 International Congress

    Comparison of Motor, Non-motor, Social Aspects between Men with Parkinson’s Disease with and without Erectile Dysfunction

    K. Nobrega, B. Souza, B. Alexandre, M. Silva, A. Frazao, A. Roque, I. Nascimento, ME. Piemonte (Sao Paulo, Brazil)

    Objective: This study aimed to compare motor, non-motor, and social aspects of men with PD who have and do not have ED. Background: Sexual dysfunction…
  • 2024 International Congress

    Plasma NFL predicting fatigue conversion in early Parkinson’s disease

    NN. Che (Chengdu, China)

    Objective: we explore if there was an association between plasma NFL and different fatigue subtypes and whether baseline plasma NFL level can predict fatigue subtype…
  • 2024 International Congress

    Gender Disparities in Depressive Symptoms among Hispanic Parkinson’s Disease Patients: A Cross-Sectional Study

    C. Rodriguez-Alarcon, D. Piana-Castillo, G. Faggioni-Sanchez, D. Bustamante-Mieles, C. Cevallos-Velasco, M. Barreiro-Guillén, R. Santibanez-Vasquez (Guayaquil, Ecuador)

    Objective: Investigate gender-specific disparities in depressive symptoms among Hispanic Parkinson's disease (PD) patients using Center for Epidemiologic Studies Depression Scale (CES-D) scores. Background: PD not…
  • 2024 International Congress

    Rural Tanzania’s Wide “PD Gap” Through the Decades

    M. Dekker, S. Urasa, W. Howlett, R. Morton, J. Josephat, R. Walker (Moshi, United Republic of Tanzania)

    Objective: To provide an impression of the Parkinson’s disease (PD) diagnosis and treatment gap across 4 decades in rural Sub Saharan Africa (SSA). Background: PD…
  • 2024 International Congress

    Association between Dipeptidyl Peptidase-4 Inhibitor Usage and Mortality in Parkinson’s Disease: a nation-wide study

    M. Park, K. Baik, I. Hong, M. Baek (Gwangmyeong, Republic of Korea)

    Objective: To investigate whether usage of dipeptidyl peptidase IV inhibitors (DPP4i) is associated decreased mortality in Parkinson’s disease (PD). Background: Type 2 diabetes mellitus (T2DM)…
  • 2024 International Congress

    Self-perception of Health and Depressive Symptomatology in Patients with Idiopathic Parkinson’s Disease without Dementia (IPDWD). Preliminary Data from a New Scale Specifically for Measuring Depression in Patients with IPDWD.

    S. Ospina-Otalvaro, C A. Hurtado-Gonzalez, J F. Ayala-Rico, J M. Márquez, M I. Ortiz Agudelo, C O. Moreno, K. Rivera, F. Rojas, S. Guerrero (Cali, Colombia)

    Objective: To identify whether depressive symptomatology correlates with self-perception of health in patients with IPDWD. Background: Parkinson's disease is a neurodegenerative pathology characterized by motor…
  • « Previous Page
  • 1
  • …
  • 29
  • 30
  • 31
  • 32
  • 33
  • …
  • 338
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Life expectancy with and without Parkinson’s disease in the general population
    • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
    • An atypical and interesting feature of Parkinson´s disease
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley